Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cambridge Nutritional SciencesFRA:RVKA Cyclically Adjusted PS Ratio is 0.20 as of Jul. 20, 2026, which is 69% below its 10-year median of 0.64. The stock has 3 warning signs investors should review. Among 521 Medical Devices & Instruments companies, Cambridge Nutritional Sciences ranks better than 93.47% on this metric.
The historical rank and industry rank for Cambridge Nutritional Sciences's Cyclically Adjusted PS Ratio or its related term are showing as below:
FRA:RVKA'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.17 Med: 0.64 Max: 8.95
Current: 0.22
During the past 13 years, Cambridge Nutritional Sciences's highest Cyclically Adjusted PS Ratio was 8.95. The lowest was 0.17. And the median was 0.64.
FRA:RVKA's Cyclically Adjusted PS Ratio is ranked better than 93.47% of 521
companies
in the Medical Devices & Instruments industry
Industry Median: 2.28
vs FRA:RVKA: 0.22
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Cambridge Nutritional Sciences's adjusted revenue per share data of for the fiscal year that ended in Mar25 was €0.042. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €0.07 for the trailing ten years ended in Mar25.
Shiller PE for Stocks: The True Measure of Stock Valuation
Cambridge Nutritional Sciences (FRA:RVKA) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Cambridge Nutritional Sciences Cyclically Adjusted PS Ratio Related Terms
Cambridge Nutritional Sciences Cyclically Adjusted PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cambridge Nutritional Sciences Cyclically Adjusted PS Ratio Chart
FRA:RVKA vs ISRG, BDX, MDLN: Cyclically Adjusted PS Ratio Comparison
For the Medical Instruments & Supplies subindustry, Cambridge Nutritional Sciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cambridge Nutritional Sciences Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cambridge Nutritional Sciences's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Cambridge Nutritional Sciences's Cyclically Adjusted PS Ratio falls into.
Cambridge Nutritional Sciences Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 0.20 mean?
Cambridge Nutritional Sciences (FRA:RVKA) has a Cyclically Adjusted PS Ratio of 0.20 as of Jul. 20, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cambridge Nutritional Sciences and its competitors. This is 69% below median its historical median of 0.64. Over the past decade, Cambridge Nutritional Sciences' Cyclically Adjusted PS Ratio has ranged from 0.17 to 8.95. According to the industry distribution chart, Cambridge Nutritional Sciences ranks #34 out of 521 companies in the Medical Devices & Instruments industry, placing it in the top 6.5%.
Is Cambridge Nutritional Sciences' Cyclically Adjusted PS Ratio too high?
Cambridge Nutritional Sciences' current Cyclically Adjusted PS Ratio of 0.20 is 69% below median its 10-year median of 0.64. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 8.95. The Medical Devices & Instruments industry median Cyclically Adjusted PS Ratio is 2.28. Cambridge Nutritional Sciences' value of 0.20 is 91.2% below this industry median. Based on the distribution chart, Cambridge Nutritional Sciences ranks #34 out of 521 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Cambridge Nutritional Sciences' Cyclically Adjusted PS Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Cambridge Nutritional Sciences ranks #34 out of 521 companies for Cyclically Adjusted PS Ratio. This places Cambridge Nutritional Sciences in the top 7% of its industry — outperforming the majority of peers. The industry median Cyclically Adjusted PS Ratio is 2.28. Cambridge Nutritional Sciences' value of 0.20 is 91.2% below this benchmark. Historically, Cambridge Nutritional Sciences' own Cyclically Adjusted PS Ratio has ranged from 0.17 to 8.95 over the past decade. While the company's 10-year median is 0.64 vs. the industry median of 2.28, Cambridge Nutritional Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Medical Devices & Instruments company?
The median Cyclically Adjusted PS Ratio among Medical Devices & Instruments companies is 2.28, based on 521 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cambridge Nutritional Sciences's current Cyclically Adjusted PS Ratio of 0.20 is 91.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cambridge Nutritional Sciences and its competitors. For the Medical Devices & Instruments industry, the median Cyclically Adjusted PS Ratio is 2.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cambridge Nutritional Sciences's current Cyclically Adjusted PS Ratio is 0.20, which is 69% below median its own 10-year median of 0.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cambridge Nutritional Sciences stock overvalued right now?
Based on GuruFocus' analysis, Cambridge Nutritional Sciences (FRA:RVKA) is currently considered Possible Value Trap. The stock's GF Value™ is €0.02, compared to a current price of €0.01 — trading 30% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 0.20, which is 69% below median its 10-year median of 0.64 and 91.2% below the Medical Devices & Instruments industry median of 2.28. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Cambridge Nutritional Sciences (FRA:RVKA), the current Cyclically Adjusted PS Ratio is 0.20 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cambridge Nutritional Sciences Business Description
Cambridge Nutritional Sciences PLC is a medical diagnostics company specializing in the development, manufacture, and distribution of food sensitivity test kits. Its product portfolio includes tests designed to detect immune reactions to various foods, helping healthcare professionals and patients identify dietary and lifestyle changes to improve long-term health and wellbeing. The company operates in the United Kingdom and serves the customer base across various countries through laboratories and healthcare providers. It generates revenue by selling diagnostic kits and providing clinical analysis services centered on food sensitivity and gut health. The group has two reportable segments: Health and Nutrition; and Corporate. The Health and Nutrition segment generates majority revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:RVKA has been successfully added to your 
